August 2026 New Product Launch: AqT® Site-Specific Antibody Biotinylation and Biotin-BSA Drug Conjugates
Posted by Yumei Huang on 27th Aug 2026
Building on our site-specific antibody-drug conjugation (ADC) technologies, CellMosaic® is launching an AqueaTether®-enabled antibod